EP0290442A4 - Composes pharmacologiquement actifs et leurs melanges, compositions organiques et sels metalliques. - Google Patents

Composes pharmacologiquement actifs et leurs melanges, compositions organiques et sels metalliques.

Info

Publication number: EP0290442A4
Authority: EP; European Patent Office
Prior art keywords: mixtures; metal salts; active compounds; pharmacologically active; organic compositions
Prior art date: 1986-11-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP19870900420

Other languages

German (de)

English (en)

Other versions

EP0290442A1 (fr

Inventor

Russell T Jordan

Larry M Allen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Abeona Therapeutics Inc

Original Assignee

Chemex Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-11-19

Filing date

1986-11-19

Publication date

1990-07-03

1986-11-19 Application filed by Chemex Pharmaceuticals Inc filed Critical Chemex Pharmaceuticals Inc

1988-11-17 Publication of EP0290442A1 publication Critical patent/EP0290442A1/fr

1990-07-03 Publication of EP0290442A4 publication Critical patent/EP0290442A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Inorganic Chemistry (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP19870900420 1986-11-19 1986-11-19 Composes pharmacologiquement actifs et leurs melanges, compositions organiques et sels metalliques. Withdrawn EP0290442A4 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US1986/002547 WO1988003805A1 (fr)	1986-11-19	1986-11-19	Composes pharmacologiquement actifs et leurs melanges, compositions organiques et sels metalliques

Publications (2)

Publication Number	Publication Date
EP0290442A1 EP0290442A1 (fr)	1988-11-17
EP0290442A4 true EP0290442A4 (fr)	1990-07-03

Family

ID=22195725

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP19870900420 Withdrawn EP0290442A4 (fr)	1986-11-19	1986-11-19	Composes pharmacologiquement actifs et leurs melanges, compositions organiques et sels metalliques.

Country Status (4)

Country	Link
EP (1)	EP0290442A4 (fr)
JP (1)	JPH01501791A (fr)
AU (1)	AU6866291A (fr)
WO (1)	WO1988003805A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1990012563A1 (fr) *	1989-04-24	1990-11-01	Board Of Regents, The University Of Texas System	Compositions et procedes d'amelioration des caracteristiques d'aspect, croissance, ou cicatrisation cosmetique de tissus
HUT66375A (en) *	1991-05-16	1994-11-28	Wu Tai Wing	Pharmaceutical composition comprising purpurogallin useful as an antioxidant and cytoprotective agent
US5248668A (en) *	1991-05-16	1993-09-28	Wintek Consulting Ltd.	Use of purpurogallin and glycosides thereof in treating ischemia in mammals
FR2686512B1 (fr) *	1992-01-28	1995-06-30	Ir2M	Compositions pharmaceutiques contenant comme principe actif des associations de vanadium et/ou de niobium avec des derives du pyrocatechol.
US5702694A (en) *	1993-08-17	1997-12-30	Schering-Plough Healthcare Products, Inc.	Compositions for treating corns, calluses and warts
WO1995024894A2 (fr) *	1994-03-14	1995-09-21	The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services	Utilisation d'inhibiteurs de la lipoxygenase en tant qu'agents therapeutiques et d'intervention anticancereux
GB9405046D0 (en) *	1994-03-15	1994-04-27	Unilever Plc	Skin treatment composition
JPH0892157A (ja) *	1994-05-02	1996-04-09	F Hoffmann La Roche Ag	プルプロガリン誘導体
US5827898A (en) *	1996-10-07	1998-10-27	Shaman Pharmaceuticals, Inc.	Use of bisphenolic compounds to treat type II diabetes
FI980216A0 (fi) *	1998-01-30	1998-01-30	Bene Pharma Oy	Medicin foer behandling av vaorfor
US7846919B2 (en) *	1998-02-10	2010-12-07	Dermex Pharmaceuticals, Llc	Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions
EP1150967A4 (fr) *	1998-10-20	2003-03-05	Shea Farn Yeh	Composes et methodes therapeutiques
EP1200104A1 (fr) *	1999-07-09	2002-05-02	Cancer2 Inc.	Compositions contenant du cadmium
US7033615B2 (en)	1999-07-09	2006-04-25	Cancer2 Inc.	Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues
JP4570184B2 (ja) *	1999-08-18	2010-10-27	卓二田中	抗腫瘍剤
KR100824075B1 (ko) *	2000-07-28	2008-04-22	이뮤파름 에이피에스	일반 감기, 알레르기성 비염 및 호흡기에 관련된 감염 증상의 치료 방법
US6475526B1 (en) *	2001-06-05	2002-11-05	Jeffrey B. Smith	Zinc containing compositions for anti-viral use
US8232277B2 (en) *	2006-10-02	2012-07-31	Erimos Pharmaceuticals Llc	Tetra-O-substituted butane-bridge modified NDGA derivatives, their synthesis and pharmaceutical use
CN102131766B (zh)	2008-08-25	2013-12-11	杜邦电子聚合物公司	丙酸酯和其制备方法
RS62051B1 (sr)	2010-08-18	2021-07-30	Biosplice Therapeutics Inc	Diketoni i hidroksiketoni kao aktivatori katenin signalnog puta
WO2014028657A1 (fr)	2012-08-15	2014-02-20	Mimedx Group, Inc	Greffes de tissu placentaire renforcées et procédés de fabrication et d'utilisation de celles-ci
US9943551B2 (en)	2012-08-15	2018-04-17	Mimedx Group, Inc.	Tissue grafts composed of micronized placental tissue and methods of making and using the same
US9180145B2 (en)	2012-10-12	2015-11-10	Mimedx Group, Inc.	Compositions and methods for recruiting and localizing stem cells
US8946163B2 (en)	2012-11-19	2015-02-03	Mimedx Group, Inc.	Cross-linked collagen comprising metallic anticancer agents
US9155799B2 (en)	2012-11-19	2015-10-13	Mimedx Group, Inc.	Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent
WO2014113733A1 (fr)	2013-01-18	2014-07-24	Mimedx Group, Inc.	Procédés de traitement d'états cardiaques
US10206977B1 (en)	2013-01-18	2019-02-19	Mimedx Group, Inc.	Isolated placental stem cell recruiting factors
US9533976B2 (en)	2013-02-22	2017-01-03	Samumed, Llc	γ-diketones as WNT/β-catenin signaling pathway activators
US10029030B2 (en)	2013-03-15	2018-07-24	Mimedx Group, Inc.	Molded placental tissue compositions and methods of making and using the same
US10335433B2 (en) *	2013-04-10	2019-07-02	Mimedx Group, Inc.	NDGA polymers and metal complexes thereof
US9446142B2 (en)	2013-05-28	2016-09-20	Mimedx Group, Inc.	Polymer chelator conjugates
KR101580716B1 (ko) *	2013-05-29	2015-12-30	숙명여자대학교산학협력단	라리아 니티다 추출물로부터 분리한 화합물 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는, 여성암과 갱년기 증상의 예방 및 치료용 약학적 조성물
EP3038630B1 (fr)	2013-08-30	2020-03-18	MIMEDX Group Inc.	Compositions placentaires micronisées comprenant un chélateur
AU2015206236B2 (en)	2014-01-17	2020-02-20	Mimedx Group, Inc.	Method for inducing angiogenesis
KR102165385B1 (ko)	2014-08-20	2020-10-15	사뮤메드, 엘엘씨	피부 노화 및 주름의 치료 및 예방을 위한 감마-디케톤
WO2016033385A1 (fr)	2014-08-28	2016-03-03	Mimedx Group, Inc.	Greffe de tissu renforcée par collagène
CN114163411A (zh) *	2021-11-16	2022-03-11	宁波大学	一种对映体纯二氢杨梅素制备方法
ES2994670A1 (es)	2023-07-24	2025-01-29	Univ Sevilla	Nuevos compuestos derivados de morina, procedimiento de obtención y usos dados a los mismos

Citations (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR7760M (fr) *	1968-11-22	1970-03-16
US4084006A (en) *	1976-06-18	1978-04-11	Leach Byron E	Method of using dialkylphenols an antiviral agents
US4268517A (en) *	1979-08-30	1981-05-19	Continental Pharma	Pharmaceutical composition and therapeutical method for treating degenerative affections of the articular cartilage
EP0037800A2 (fr) *	1980-04-03	1981-10-14	Zyma SA	Utilisation de dérivés O-substitués de (+)-cyanidanol-3 comme composés doués de propriétés immunomodulatrices
US4350707A (en) *	1976-02-05	1982-09-21	Research Corporation	Inactivation of lipid containing viruses with butylated hydroxytoluene
WO1986006586A1 (fr) *	1985-05-03	1986-11-20	Chemex Pharmaceuticals, Inc.	Excipients pharmaceutiques reducteurs du flux transdermique
WO1988001509A1 (fr) *	1986-08-25	1988-03-10	Chemex Pharmaceuticals, Inc.	Compositions pharmacologiquement actives de butanes catecholiqueset de zinc
WO1988003026A1 (fr) *	1986-10-28	1988-05-05	Chemex Pharmaceuticals, Inc.	Compositions de butanes catecholiques avec du zinc

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3934034A (en) *	1972-08-21	1976-01-20	Sandoz, Inc.	Hydroxy substituted diphenylalkyls for treatment of lipidemia
DE2658307C2 (de) *	1976-12-22	1979-03-15	Klinge Pharma Gmbh & Co, 8000 Muenchen	Di-O'-hydroxyphenyD-alkanverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

1986
- 1986-11-19 JP JP62500359A patent/JPH01501791A/ja active Pending
- 1986-11-19 EP EP19870900420 patent/EP0290442A4/fr not_active Withdrawn
- 1986-11-19 WO PCT/US1986/002547 patent/WO1988003805A1/fr not_active Application Discontinuation
1991
- 1991-01-04 AU AU68662/91A patent/AU6866291A/en not_active Abandoned

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR7760M (fr) *	1968-11-22	1970-03-16
US4350707A (en) *	1976-02-05	1982-09-21	Research Corporation	Inactivation of lipid containing viruses with butylated hydroxytoluene
US4084006A (en) *	1976-06-18	1978-04-11	Leach Byron E	Method of using dialkylphenols an antiviral agents
US4268517A (en) *	1979-08-30	1981-05-19	Continental Pharma	Pharmaceutical composition and therapeutical method for treating degenerative affections of the articular cartilage
EP0037800A2 (fr) *	1980-04-03	1981-10-14	Zyma SA	Utilisation de dérivés O-substitués de (+)-cyanidanol-3 comme composés doués de propriétés immunomodulatrices
WO1986006586A1 (fr) *	1985-05-03	1986-11-20	Chemex Pharmaceuticals, Inc.	Excipients pharmaceutiques reducteurs du flux transdermique
WO1988001509A1 (fr) *	1986-08-25	1988-03-10	Chemex Pharmaceuticals, Inc.	Compositions pharmacologiquement actives de butanes catecholiqueset de zinc
WO1988003026A1 (fr) *	1986-10-28	1988-05-05	Chemex Pharmaceuticals, Inc.	Compositions de butanes catecholiques avec du zinc

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8803805A1 *

Also Published As

Publication number	Publication date
JPH01501791A (ja)	1989-06-22
EP0290442A1 (fr)	1988-11-17
AU6866291A (en)	1991-03-14
WO1988003805A1 (fr)	1988-06-02

Publication	Publication Date	Title
EP0290442A4 (fr)	1990-07-03	Composes pharmacologiquement actifs et leurs melanges, compositions organiques et sels metalliques.
GB2200109B (en)	1991-07-03	New pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
ZA878953B (en)	1988-05-24	New pharmacologically active compounds,methods for the preparation thereof and compositions containing the same
OA09148A (en)	1991-10-31	Pharmacologically active CNS compounds.
NL192201B (nl)	1996-11-01	Farmacologisch actieve fenylaminoalkylcyclobutaanverbindingen en prepa- raten die deze verbindingen bevatten.
FI904444A0 (fi)	1990-09-10	Aktiva limkompositioner.
NO852561L (no)	1985-12-30	Farmakologisk aktive, substituerte benzamider.
IT1190824B (it)	1988-02-24	Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
NZ219606A (en)	1989-09-27	1,1-disubstituted-cyclopropane derivatives and fungicidal compositions
IT8820550A0 (it)	1988-05-12	Benzammidi sostituite farmacologicamente attive.
FI874166L (fi)	1988-03-25	Anvaendning av 2',3'-dideoxicytidin -2'-en foer behandling av patienter infekterade med retrovirus.
DE3585873D1 (de)	1992-05-21	Vinylbenzyl-2,2,6,6-tetramethylpiperidine.
ZA782781B (en)	1979-06-27	Pharmacologically active substituted 1,2,4-triazines
IT8521235A0 (it)	1985-06-21	Composti farmacologicamente attivi.
IT8920405A0 (it)	1989-05-08	Aminoimidazopiridine farmacologicamente attive.
IT8619121A0 (it)	1986-01-20	Alchiloli derivati farmacologicamente attivi.
FI922720A0 (fi)	1992-06-12	Farmakologiskt aktiva amidkarboxylatderivat.
GB8622090D0 (en)	1986-10-22	Pharmacologically active compounds
KR890700028A (ko)	1989-03-02	약제학적 활성화합물 및 이의 혼합물, 유기조성물 및 금속염
ATE85185T1 (de)	1993-02-15	1,4-naphthochinonderivate enthaltende rodentizide zusammensetzungen.
EP0634394A3 (fr)	1995-07-26	Composé organique fluoré.
NZ219949A (en)	1990-07-26	Cyanoacetamido derivatives having fungicidal activity, fungicidal compositions and intermediate compounds
EP0419157A3 (en)	1991-08-28	Pharmacologically active compound., preparation and use
AU6779487A (en)	1988-06-16	Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts
FI865244A (fi)	1987-06-21	Foerfarande foer framstaellning av optiskt aktiva 2-klor-12-(3-dimetylamino-2-metylpropyl)-12h-dibenzo-/d,g//1,3,6/ dioxazociner.

Legal Events

Date	Code	Title	Description
1988-10-01	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1988-11-17	17P	Request for examination filed	Effective date: 19880718
1988-11-17	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE
1989-06-07	RAP3	Party data changed (applicant data changed or rights of an application transferred)	Owner name: CHEMEX PHARMACEUTICALS, INC.
1989-06-28	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: CHEMEX PHARMACEUTICALS, INC.
1990-07-18	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: CHEMEX PHARMACEUTICALS, INC.
1990-08-22	A4	Supplementary search report drawn up and despatched	Effective date: 19900703
1991-08-14	17Q	First examination report despatched	Effective date: 19910701
1992-05-20	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
1992-07-08	18D	Application deemed to be withdrawn	Effective date: 19920114